All News

While not too many bench pharmacists get a lunch hour, creative solutions are still possible. In theory, anyway

Effective communication is the keystone of pharmacy ethics in daily practice

Data from the RE-MEDY trial suggest that Pradaxa is as effective as warfarin for long-term, extended antithrombotic therapy in patients who have already received at least three months of anticoagulation for VTE

Patients will consult with pharmacists, RNs, and PAs during health consultations offered right in their own neighborhoods

The popular guide by Harold Silverman, PhD, is now available as an app for iPhones, iPods, and iPads

Built-in timer notes when bottle was last opened

Shenandoah University, RxAlly, RealCME, and Kerr Drug to collaborate under Pfizer grant

Associations issues results of Medication Management in Care Transitions project

Drug Topics readers weigh in (04-15-2013)

Topical products for pain relief

New Rx, generics, OTC, and devices

The increase in utilization of generic drugs is driving costs down, while the increase in specialty pharmacy utilization is driving costs up, according to the 2013 CVS Caremark annual Insights Report.

Will FDA classify hydrocodone as Schedule III, Schedule II, or somewhere in between?

Guideline-directed medical therapy for heart failure (HF) is highly cost-effective and able to produce significant health gains for individuals with mild to moderate disease, according a study published April 2 in the Journal of the American College of Cardiology.

First new NVP approval in 50 years brings back 30-year-old drug

The antiarrhythmia drug amiodarone appears to be linked to a higher risk of cancer in men, specifically those who receive higher cumulative defined daily doses within the first year of treatment, according to a retrospective study published online April 8 in Cancer.

Ruling clears obstacles judge said were politically influenced

Pharmacists and other healthcare providers are still confusing Prilosec (omeprazole) and Prozac (fluoxetine) prescriptions, according to a new report from the Institute for Safe Medication Practices (ISMP).

The Academy of Managed Care Pharmacy has changed the foundation’s name to the Academy of Managed Care Pharmacy Foundation. In addition, it has elected four new members to its board of trustees, during the AMCP’s 25th annual meeting and exposition in San Diego.

The IMS report tracked impact of care on Managed Medicaid beneficiaries in Kentucky, New Jersey, New York, and Ohio since 2011 in three therapeutic areas: antipsychotics, diabetes agents, and respiratory medications

Restrictive state Medicaid policies are delaying care because of cost and should be reconsidered, according to a recent NEJM letter to the editor.

Walgreens announced April 2 that it is expanding its Balance Rewards program to give extra points to customers for completing health-related activities.

NCPA responds to CMS' final call letter for 2014 PDPs

First winners of the "Pharmacy Is Right for Me Student Innovation Challenge" are announced

A review of the literature provides moderate strength evidence that sublingual immunotherapy is effective for the treatment of allergic rhinitis and asthma, according to an article published March 27 in the JAMA.

The third edition of APhA's pocket reference is now available

Diabetes drug canagliflozin (Invokana, Janssen Pharmaceuticals) is the first drug approved by the FDA in a new class known as sodium-glucose co-transporter 2 (SGLT2) inhibitors.